Audited Supplier
Porcine Circovirus Vaccine Type2, Inactivated (Strain DBN-SX07)
[Veterinary Drug Name/ Generic Name]
Porcine Circovirus Vaccine Type2, Inactivated (Strain DBN-SX07)
[Main content and Composition]
The product contains inactivated Porcine Circovirus Type2 (Strain DBN-SX07). Content of Porcine Circovirus Type2 (Strain DBN-SX07) per ml shall be≥ 105.5TCID50.
[Characteristic] Milky white or light pink emulsion
[Indication and Effect] For prevention of Porcine Circovirus Type2, the immune period will be 4 months.
[Usage and Dosage] Intramuscular injection at neck area. For the healthy piglet, first administration at 14-21 days and second administration after 14 days interval, 1.0ml/piglet every time.
[Adverse Effect] None
[Precautions]
1. For healthy piglets only.
2. No frozen is allowed.
3. The vaccine shall be warmed until room temperature and shaken well before administration
4. After the vaccine is open, used up within same day.
5. The remaining vaccines, vaccine bottle and injection equipment shall be harmless treated
[Presentation] 20ml/bottle
[Package] 20ml * 200 bottle/carton
[Storage] Store at 2-8ºC.
[Shelf life] 12 months from production date.
[Drug Approval No.] Shou Yao Sheng Zi 010371076.
[Manufacturer] Beijing Sinder-vet Technology Co., Ltd., China
( A subsidiary of Shandong Sinder Technology Co., Ltd., China)
[Exporter] Shandong Sinder Technology Co., Ltd., China
Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.
Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!
Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.
Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.
